Last updated on December 2019
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
Brief description of study
The reason for this study is to see if baricitinib is safe and effective in adults with severe or very severe alopecia areata (AA).
Clinical Study Identifier: NCT03899259
